{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T21:19:09Z","timestamp":1793395149141,"version":"4.5.0"},"update-to":[{"DOI":"10.1371\/journal.pmed.1004519","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T00:00:00Z","timestamp":1758672000000}}],"reference-count":51,"publisher":"Public Library of Science (PLoS)","issue":"9","license":[{"start":{"date-parts":[[2025,9,19]],"date-time":"2025-09-19T00:00:00Z","timestamp":1758240000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100013057","name":"Heffter Research Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","award":["UL1TR002538"],"award-info":[{"award-number":["UL1TR002538"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01DA058621"],"award-info":[{"award-number":["R01DA058621"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100030692","name":"Intramural Research Program, National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["UG3DA062106"],"award-info":[{"award-number":["UG3DA062106"]}],"id":[{"id":"10.13039\/100030692","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosmedicine.org"],"crossmark-restriction":false},"short-container-title":["PLoS Med"],"abstract":"<jats:sec id=\"sec001\">\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Depression and burnout, which are common among healthcare workers, were exacerbated by the COVID-19 pandemic. Mindfulness-Based Stress Reduction (MBSR) and psilocybin have been reported to reduce depressive symptoms, but the efficacy of the combination requires comparison to an active treatment control. We sought to evaluate the safety and preliminary efficacy of psilocybin and MBSR versus MBSR alone for frontline healthcare providers with symptoms of depression and burnout related to the COVID-19 pandemic. We hypothesized that psilocybin would augment the antidepressant effects of MBSR in this population.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec002\">\n                    <jats:title>Methods and findings<\/jats:title>\n                    <jats:p>\n                      We conducted a randomized controlled trial that enrolled physicians and nurses with frontline clinical work during the COVID-19 pandemic and symptoms of depression and burnout. (ClinicalTrials.gov Identifier: NCT05557643) Participants were enrolled between January 2nd, 2023 and January 16th, 2024, and randomized in a 1:1 ratio to either an 8-week MBSR curriculum alone or an 8-week MBSR curriculum plus group psilocybin-assisted psychotherapy (PAP) with 25\u2009mg psilocybin. Evaluation of safety and feasibility of enrollment and retention was a primary objective of the study. The primary efficacy endpoint was change in depressive symptoms, as measured by the Quick Inventory of Depressive Symptoms (QIDS-SR-16) at 2 weeks post-intervention. Symptoms of depression and burnout were assessed at baseline, and 2 weeks and 6 months post-intervention utilizing the Quick Inventory of Depressive Symptoms (QIDS-SR-16) and Maslach Burnout Inventory Human Services Survey for Medical Professionals (MBI-HSS-MP), respectively. Secondary outcome measures included the Demoralization Scale (DS-II) and the Watt\u2019s Connectedness Scale (WCS). Adverse events (AEs) and suicidality were assessed through a 6-month follow-up. Twenty-five participants were enrolled and randomized. Safety was a study outcome and assessed by rate and severity of AEs and any incident suicidality or significant mental health symptoms. Baseline and outcome data were summarized using descriptive statistics, with continuous variables reported as means and standard deviations. We recorded 12 study-related, Grade 1\u20132 AEs and no serious AEs. In a linear mixed model analysis (LMM), the MBSR + PAP arm evidenced a significantly larger decrease in QIDS-SR-16 score than the MBSR-only arm from baseline to 2-weeks post-intervention (between-groups effect = 4.6, 95% CI [1.51, 7.70];\n                      <jats:italic>p<\/jats:italic>\n                      = 0.008). This effect waned at the 6-month follow-up. Secondary outcome measures for burnout (subscales of the MBI-HSS-MP), demoralization (DS II), and connectedness (WCS) favored the MBSR + PAP arm; however, these effects did not survive correction for multiple comparisons. A mixed RM-ANCOVA was conducted to control for baseline differences in outcome measures. Sensitivity analyses were conducted, adjusting for baseline differences in gender and clustering within group cohorts. Study limitations that affect the generalizability of results include a small sample size, homogenous study population, and significant differences in intervention intensity.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec003\">\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>This trial met its primary endpoint: group psilocybin-assisted therapy plus MBSR was associated with clinically significant improvement in depressive symptoms without serious AEs and with greater reduction in symptoms than MBSR alone. Our findings suggest that integrating psilocybin with mindfulness training may represent a promising treatment for depression and burnout among physicians and nurses. Larger trials are needed to establish efficacy, generalizability, and durability of these effects.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1371\/journal.pmed.1004519","type":"journal-article","created":{"date-parts":[[2025,9,19]],"date-time":"2025-09-19T21:51:58Z","timestamp":1758318718000},"page":"e1004519","update-policy":"https:\/\/doi.org\/10.1371\/journal.pmed.corrections_policy","source":"Crossref","is-referenced-by-count":15,"title":["Psilocybin-assisted group psychotherapy and mindfulness-based stress reduction for frontline healthcare provider COVID-19-related depression and burnout: A randomized controlled trial"],"prefix":"10.1371","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0118-1053","authenticated-orcid":true,"given":"Benjamin R.","family":"Lewis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Hendrick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0409-5273","authenticated-orcid":true,"given":"Kevin","family":"Byrne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2214-8324","authenticated-orcid":true,"given":"Madeleine","family":"Odette","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chaorong","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric L.","family":"Garland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2025,9,19]]},"reference":[{"issue":"7","key":"pmed.1004519.ref001","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1056\/NEJMp2207252","article-title":"Confronting health worker burnout and well-Being","volume":"387","author":"VH Murthy","year":"2022","journal-title":"N Engl J Med"},{"key":"pmed.1004519.ref002","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1097\/JOM.0000000000002263","article-title":"Burnout among primary care healthcare workers during the COVID-19 pandemic","volume":"63","author":"EA Apaydin","year":"2021","journal-title":"J Occup Environ Med"},{"key":"pmed.1004519.ref003","doi-asserted-by":"crossref","first-page":"171","DOI":"10.2147\/LRA.S240564","article-title":"Burnout in healthcare workers: prevalence, impact and preventative strategies","volume":"13","author":"S De Hert","year":"2020","journal-title":"Local Reg Anesth"},{"key":"pmed.1004519.ref004","doi-asserted-by":"crossref","first-page":"6087","DOI":"10.3390\/ijerph20126087","article-title":"Health workers\u2019 burnout and COVID-19 pandemic: 1-year after\u2014results from a repeated cross-sectional survey","volume":"20","author":"E Gambaro","year":"2023","journal-title":"Int J Environ Res Public Health"},{"key":"pmed.1004519.ref005","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/j.bbi.2020.05.026","article-title":"Prevalence of depression, anxiety, and insomnia among healthcare workers during the COVID-19 pandemic: a systematic review and meta-analysis","volume":"88","author":"S Pappa","year":"2020","journal-title":"Brain Behav Immun"},{"issue":"2","key":"pmed.1004519.ref006","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1080\/13651501.2022.2101927","article-title":"Health care workers\u2019 mental health in the face of COVID-19: a systematic review and meta-analysis","volume":"27","author":"S Ghahramani","year":"2023","journal-title":"Int J Psychiatry Clin Pract"},{"issue":"2","key":"pmed.1004519.ref007","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1002\/wps.20311","article-title":"Understanding the burnout experience: recent research and its implications for psychiatry","volume":"15","author":"C Maslach","year":"2016","journal-title":"World Psychiatry"},{"key":"pmed.1004519.ref008","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1093\/clipsy.bpg016","article-title":"Mindfulness-based interventions in context: past, present, and future","volume":"10","author":"J Kabat-Zinn","year":"2003","journal-title":"Clin Psychol Sci Pract"},{"issue":"1","key":"pmed.1004519.ref009","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12671-020-01500-9","article-title":"The Effectiveness of mindfulness-based stress reduction on the psychological functioning of healthcare professionals: a systematic review","volume":"12","author":"SA Kriakous","year":"2021","journal-title":"Mindfulness (N Y)"},{"issue":"11","key":"pmed.1004519.ref010","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2019-032295","article-title":"Mindfulness-based interventions to reduce burnout and stress in physicians: a study protocol for a systematic review and meta-analysis","volume":"9","author":"JC Fendel","year":"2019","journal-title":"BMJ Open"},{"issue":"10","key":"pmed.1004519.ref011","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.3390\/healthcare9101342","article-title":"Mindfulness-based interventions to reduce burnout in primary healthcare professionals: a systematic review and meta-analysis","volume":"9","author":"M Salvado","year":"2021","journal-title":"Healthcare (Basel)"},{"issue":"9","key":"pmed.1004519.ref012","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1001\/jama.2023.14530","article-title":"Single-dose psilocybin treatment for major depressive disorder: a randomized clinical trial","volume":"330","author":"CL Raison","year":"2023","journal-title":"JAMA"},{"issue":"5","key":"pmed.1004519.ref013","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1001\/jamapsychiatry.2020.3285","article-title":"Effects of psilocybin-assisted therapy on major depressive disorder: a randomized clinical trial","volume":"78","author":"AK Davis","year":"2021","journal-title":"JAMA Psychiatry"},{"issue":"18","key":"pmed.1004519.ref014","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1056\/NEJMoa2206443","article-title":"Single-dose psilocybin for a treatment-resistant episode of major depression","volume":"387","author":"GM Goodwin","year":"2022","journal-title":"N Engl J Med"},{"key":"pmed.1004519.ref015","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.neuroimage.2019.04.009","article-title":"Psilocybin-assisted mindfulness training modulates self-consciousness and brain default mode network connectivity with lasting effects","volume":"196","author":"L Smigielski","year":"2019","journal-title":"Neuroimage"},{"issue":"1","key":"pmed.1004519.ref016","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1177\/0269881117731279","article-title":"Psilocybin-occasioned mystical-type experience in combination with meditation and other spiritual practices produces enduring positive changes in psychological functioning and in trait measures of prosocial attitudes and behaviors","volume":"32","author":"RR Griffiths","year":"2018","journal-title":"J Psychopharmacol"},{"issue":"1","key":"pmed.1004519.ref017","doi-asserted-by":"crossref","first-page":"7211","DOI":"10.1038\/s41598-024-55726-x","article-title":"Psilocybin enhances insightfulness in meditation: a perspective on the global topology of brain imaging during meditation","volume":"14","author":"B Singer","year":"2024","journal-title":"Sci Rep"},{"issue":"2","key":"pmed.1004519.ref018","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1021\/acsptsci.1c00034","article-title":"Combining Psychedelic and mindfulness interventions: synergies to inform clinical practice","volume":"4","author":"JE Payne","year":"2021","journal-title":"ACS Pharmacol Transl Sci"},{"key":"pmed.1004519.ref019","doi-asserted-by":"crossref","first-page":"224","DOI":"10.3389\/fpsyt.2020.00224","article-title":"Depression, mindfulness, and psilocybin: possible complementary effects of mindfulness meditation and psilocybin in the treatment of depression. A Review","volume":"11","author":"K Heuschkel","year":"2020","journal-title":"Front Psychiatry"},{"issue":"6","key":"pmed.1004519.ref020","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1007\/s43440-023-00551-8","article-title":"Mindfulness meditation and psychedelics: potential synergies and commonalities","volume":"75","author":"P Holas","year":"2023","journal-title":"Pharmacol Rep"},{"key":"pmed.1004519.ref021","article-title":"Can psychedelic use benefit meditation practice? Examining individual, psychedelic, and meditation-related factors","author":"Z Jiwani","year":"2024","journal-title":"medRxiv"},{"key":"pmed.1004519.ref022","doi-asserted-by":"crossref","first-page":"104724","DOI":"10.1016\/j.neubiorev.2022.104724","article-title":"Don\u2019t be afraid, try to meditate- potential effects on neural activity and connectivity of psilocybin-assisted mindfulness-based intervention for social anxiety disorder: a systematic review","volume":"139","author":"CL Felsch","year":"2022","journal-title":"Neurosci Biobehav Rev"},{"issue":"5","key":"pmed.1004519.ref023","first-page":"533","article-title":"Comparing neural correlates of consciousness: from psychedelics to hypnosis and meditation","volume":"9","author":"FF Moujaes","year":"2024","journal-title":"Biol Psychiatry Cogn Neurosci Neuroimaging"},{"issue":"12","key":"pmed.1004519.ref024","article-title":"Psilocybin therapy for clinicians with symptoms of depression from frontline care during the COVID-19 Pandemic: a randomized clinical trial","volume":"7","author":"AL Back","year":"2024","journal-title":"JAMA Netw Open"},{"issue":"3","key":"pmed.1004519.ref025","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.jpainsymman.2023.06.006","article-title":"HOPE: a pilot study of psilocybin enhanced group psychotherapy in patients with cancer","volume":"66","author":"BR Lewis","year":"2023","journal-title":"J Pain Symptom Manage"},{"issue":"7","key":"pmed.1004519.ref026","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1002\/cncr.35010","article-title":"Psilocybin-assisted group therapy in patients with cancer diagnosed with a major depressive disorder","volume":"130","author":"M Agrawal","year":"2024","journal-title":"Cancer"},{"key":"pmed.1004519.ref027","doi-asserted-by":"crossref","first-page":"100538","DOI":"10.1016\/j.eclinm.2020.100538","article-title":"Psilocybin-assisted group therapy for demoralized older long-term AIDS survivor men: an open-label safety and feasibility pilot study","volume":"27","author":"BT Anderson","year":"2020","journal-title":"EClinicalMedicine"},{"key":"pmed.1004519.ref028","article-title":"Quality of reporting on psychological interventions in psychedelic treatments: a systematic review","author":"C Seybert","year":"2024","journal-title":"Lancet Psychiatry"},{"key":"pmed.1004519.ref029","volume-title":"Full catastrophe living","author":"J Kabat-Zinn","year":"2013"},{"key":"pmed.1004519.ref030","article-title":"Group format psychedelic-assisted therapy interventions: observations and impressions from the HOPE trial","author":"BR Lewis","year":"2023","journal-title":"J Psychedel Stud"},{"key":"pmed.1004519.ref031","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/S0006-3223(02)01866-8","article-title":"The 16-Item Quick Inventory of Depressive Symptomatology (QIDS), clinician rating (QIDS-C), and self-report (QIDS-SR): a psychometric evaluation in patients with chronic major depression","volume":"54","author":"AJ Rush","year":"2003","journal-title":"Biol Psychiatry"},{"issue":"15","key":"pmed.1004519.ref032","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1056\/NEJMoa2032994","article-title":"Trial of psilocybin versus escitalopram for depression","volume":"384","author":"R Carhart-Harris","year":"2021","journal-title":"N Engl J Med"},{"key":"pmed.1004519.ref033","doi-asserted-by":"crossref","first-page":"231","DOI":"10.4314\/ifep.v17i1.43750","article-title":"Validation of maslach burnout inventory","volume":"17","author":"AO Coker","year":"2009","journal-title":"IFE Psychologia"},{"issue":"14","key":"pmed.1004519.ref034","doi-asserted-by":"crossref","first-page":"2260","DOI":"10.1002\/cncr.30012","article-title":"Refinement and revalidation of the demoralization scale: the DS-II-external validity","volume":"122","author":"S Robinson","year":"2016","journal-title":"Cancer"},{"key":"pmed.1004519.ref035","article-title":"The posttraumatic stress disorder checklist for DSM-5 (PCL-5): development and initial psychometric evaluation","volume":"28","author":"B Ca","year":"2015","journal-title":"J Trauma Stress"},{"issue":"11","key":"pmed.1004519.ref036","doi-asserted-by":"crossref","first-page":"3461","DOI":"10.1007\/s00213-022-06187-5","article-title":"The Watts Connectedness Scale: a new scale for measuring a sense of connectedness to self, others, and world","volume":"239","author":"R Watts","year":"2022","journal-title":"Psychopharmacology (Berl)"},{"issue":"2","key":"pmed.1004519.ref037","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0005-7916(00)00012-4","article-title":"Psychometric properties of the credibility\/expectancy questionnaire","volume":"31","author":"GJ Devilly","year":"2000","journal-title":"J Behav Ther Exp Psychiatry"},{"issue":"11","key":"pmed.1004519.ref038","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1177\/0269881115609019","article-title":"Validation of the revised Mystical Experience Questionnaire in experimental sessions with psilocybin","volume":"29","author":"FS Barrett","year":"2015","journal-title":"J Psychopharmacol"},{"issue":"12","key":"pmed.1004519.ref039","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1177\/0269881116678781","article-title":"The Challenging Experience Questionnaire: characterization of challenging experiences with psilocybin mushrooms","volume":"30","author":"FS Barrett","year":"2016","journal-title":"J Psychopharmacol"},{"issue":"12","key":"pmed.1004519.ref040","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1037\/pas0000615","article-title":"The Nondual Awareness Dimensional Assessment (NADA): new tools to assess nondual traits and states of consciousness occurring within and beyond the context of meditation","volume":"30","author":"AW Hanley","year":"2018","journal-title":"Psychol Assess"},{"key":"pmed.1004519.ref041","doi-asserted-by":"crossref","first-page":"112749","DOI":"10.1016\/j.psychres.2020.112749","article-title":"The experimental effects of psilocybin on symptoms of anxiety and depression: a meta-analysis","volume":"284","author":"SB Goldberg","year":"2020","journal-title":"Psychiatry Res"},{"issue":"6","key":"pmed.1004519.ref042","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.jpsychores.2015.03.009","article-title":"Mindfulness-based stress reduction for healthy individuals: a meta-analysis","volume":"78","author":"B Khoury","year":"2015","journal-title":"J Psychosom Res"},{"key":"pmed.1004519.ref043","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.jcbs.2019.11.004","article-title":"Psychological flexibility mediates the relations between acute psychedelic effects and subjective decreases in depression and anxiety","volume":"15","author":"AK Davis","year":"2020","journal-title":"J Contextual Behav Sci"},{"issue":"1","key":"pmed.1004519.ref044","doi-asserted-by":"crossref","first-page":"8833","DOI":"10.1038\/s41598-024-58318-x","article-title":"Psychological flexibility as a mechanism of change in psilocybin-assisted therapy for major depression: results from an exploratory placebo-controlled trial","volume":"14","author":"J Sloshower","year":"2024","journal-title":"Sci Rep"},{"issue":"4","key":"pmed.1004519.ref045","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1007\/s11606-021-07055-2","article-title":"Predictors of physician compassion, empathy, and related constructs: a systematic review","volume":"37","author":"A Pavlova","year":"2022","journal-title":"J Gen Intern Med"},{"issue":"2","key":"pmed.1004519.ref046","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1007\/s00213-017-4701-y","article-title":"Psychedelics and connectedness","volume":"235","author":"RL Carhart-Harris","year":"2018","journal-title":"Psychopharmacology (Berl)"},{"key":"pmed.1004519.ref047","doi-asserted-by":"crossref","first-page":"1293243","DOI":"10.3389\/fpsyt.2023.1293243","article-title":"Group psychedelic therapy: empirical estimates of cost-savings and improved access","volume":"14","author":"E Marseille","year":"2023","journal-title":"Front Psychiatry"},{"issue":"9","key":"pmed.1004519.ref048","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1080\/17512433.2021.1933434","article-title":"Blinding and expectancy confounds in psychedelic randomized controlled trials","volume":"14","author":"SD Muthukumaraswamy","year":"2021","journal-title":"Expert Rev Clin Pharmacol"},{"key":"pmed.1004519.ref049","first-page":"1","article-title":"Assessing expectancy and suggestibility in a trial of escitalopram v. psilocybin for depression","author":"B Szigeti","year":"2024","journal-title":"Psychol Med"},{"issue":"12","key":"pmed.1004519.ref050","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1177\/0269881116675513","article-title":"Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: a randomized double-blind trial","volume":"30","author":"RR Griffiths","year":"2016","journal-title":"J Psychopharmacol"},{"issue":"2","key":"pmed.1004519.ref051","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1002\/wps.21214","article-title":"Modulating self-referential processing through meditation and psychedelics: is scientific investigation of self-transcendence clinically relevant?","volume":"23","author":"MD Sacchet","year":"2024","journal-title":"World Psychiatry"}],"updated-by":[{"DOI":"10.1371\/journal.pmed.1004519","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T00:00:00Z","timestamp":1758672000000}}],"container-title":["PLOS Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pmed.1004519","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T17:51:45Z","timestamp":1758736305000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pmed.1004519"}},"subtitle":[],"editor":[{"given":"Alexander C.","family":"Tsai,","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2025,9,19]]},"references-count":51,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2025,9,19]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pmed.1004519","relation":{},"ISSN":["1549-1676"],"issn-type":[{"value":"1549-1676","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,19]]}}}